Drug Shortage Report for FOLIC ACID INJECTION, USP
| Report ID | 107559 |
| Drug Identification Number | 02139480 |
| Brand name | FOLIC ACID INJECTION |
| Common or Proper name | Folic Acid Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | FOLIC ACID |
| Strength(s) | 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 5mg/mL, MD Vial, 10mL |
| ATC code | B03BB |
| ATC description | VITAMIN B12 AND FOLIC ACID |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-02-03 |
| Estimated end date | Unknown |
| Actual end date | 2020-04-09 |
| Shortage status | Resolved |
| Updated date | 2021-01-26 |
| Company comments | Fresenius Kabi Canada Ltd. regrets to advise that due to a production delay, we will be placing our Folic Acid Injection 5mg/mL, 10mL vials on reduced allocation. Contract customers will be allocated 50% of their historical average monthly volumes, effective today, February 3, 2020. UPDATE Allocations Increased to 150% |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-01-26 | French | Compare |
| v3 | 2021-01-26 | English | Compare |
| v2 | 2020-03-02 | French | Compare |
| v1 | 2020-03-02 | English | Compare |
Showing 1 to 4 of 4